Human experiments on the coronavirus vaccine began

Human experiments on the coronavirus vaccine began

WASHINGTON - Scientists have stepped up efforts to develop a vaccine against the spread of the coronavirus, and Oxford University and Asara Zenka in the UK are working on a single vaccine against humans. 

Both organizations recruit about 10,000 volunteers, including people of all ages.

The United States has provided 1.2 billion in funding for coronavirus vaccine trials.

The team of experts is looking for people who are mostly health workers or public service workers to try the vaccine against people so that they can tell clearly about the vaccine.

Preliminary trials began April 23 and more than 1,000 volunteers between the ages of 18 and 55 were vaccinated.

The second and third phases will involve people over the age of 56 and children between the ages of 5 and 12, Oxford University said.

Assazenka CEO Manziel Pengels says human experiments with the new vaccine have progressed rapidly as a result of Oxford scientific research.

A statement from Oxford University said it could take two to six months for the results of vaccine experiments in humans to be known.

British pharmaceutical companies have already signed agreements with the United Kingdom and the United States, paving the way for large-scale vaccine development. 

And if there is evidence that the vaccine is safe for human use and effective against the coronavirus, it will be available worldwide.

Pascal Surya, CEO of Strank, said last month that the final results would come in June or July to see how effective the vaccine would be.

 But if that momentum continues, the results could take up to six months.

On May 15, the World Health Organization approved eight vaccines for human trials. These include Medrina Inc., Innova, Pfizer Inc.,

 And biotech. Vaccines developed by two Chinese companies, Ken Sino and Sonovic, have also been approved for human trials.

In contrast, a report published Friday in the scientific medical journal Lancet states that preliminary results from the COVID 19 vaccine are indeed positive. However, they were not so enthusiastic.

The report says that China conducted initial human tests on the vaccine, to which the immunes
system responded. 

However, in some patients it had adverse effects and side effects were observed.

More than 100 vaccines are currently being developed worldwide to prevent the virus, while the World Health Organization has approved eight for human trials.

( Hamari News )